379 related articles for article (PubMed ID: 9107077)
41. Significance of p53 overexpression in bone marrow biopsies from patients with bone marrow failure: aplastic anemia, hypocellular refractory anemia, and hypercellular refractory anemia.
Elghetany MT; Vyas S; Yuoh G
Ann Hematol; 1998 Dec; 77(6):261-4. PubMed ID: 9875662
[TBL] [Abstract][Full Text] [Related]
42. [Morphological changes in peripheral blood and bone marrow in patients with myelodysplastic syndromes].
Mariańska B; Apel D; Maj S
Acta Haematol Pol; 1991; 22(1):48-53. PubMed ID: 1823967
[TBL] [Abstract][Full Text] [Related]
43. [Clinical features of cytopenia with bone marrow hypoplasia in children: an analysis of 100 cases].
Yang WY; Chen XJ; Zhang PH; Hama A; Ito M; Kojima S; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):448-52. PubMed ID: 23791060
[TBL] [Abstract][Full Text] [Related]
44. Peripheral blood and bone marrow changes in patients with acquired immunodeficiency syndrome.
Adediran IA; Durosinmi MA
Afr J Med Med Sci; 2006 Dec; 35 Suppl():85-91. PubMed ID: 18050779
[TBL] [Abstract][Full Text] [Related]
45. Cyclosporin A in myelodysplastic syndrome: a preliminary report.
Dixit A; Chatterjee T; Mishra P; Choudhary DR; Mahapatra M; Saxena R; Choudhry VP
Ann Hematol; 2005 Sep; 84(9):565-8. PubMed ID: 15809884
[TBL] [Abstract][Full Text] [Related]
46. Multicenter prospective study of clonal complications in adult aplastic anemia patients following recombinant human granulocyte colony-stimulating factor (lenograstim) administration.
Bessho M; Hotta T; Ohyashiki K; Takahashi T; Mizoguchi H; Asano S; Ikeda Y; Sakurai M; Tojo A; Kizaki M; Iwanaga M; Tomonaga M; Hirashima K
Int J Hematol; 2003 Feb; 77(2):152-8. PubMed ID: 12627850
[TBL] [Abstract][Full Text] [Related]
47. Refractory cytopenias: clinical course according to bone marrow cytology and cellularity.
Riccardi A; Giordano M; Girino M; Cazzola M; Montecucco CM; Cassano E; Danova M; Ucci G; Castello A; Coci A
Blut; 1987 Mar; 54(3):153-63. PubMed ID: 3814832
[TBL] [Abstract][Full Text] [Related]
48. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
49. Hemogram and bone marrow morphology in children with chronic aplastic anemia and myelodysplastic syndrome.
Wen JQ; Feng HL; Wang XQ; Pang JP
World J Pediatr; 2008 Feb; 4(1):36-40. PubMed ID: 18402250
[TBL] [Abstract][Full Text] [Related]
50. F-blast is a useful marker for differentiating hypocellular refractory anemia from aplastic anemia.
Choi JW; Fujino M; Ito M
Int J Hematol; 2002 Apr; 75(3):257-60. PubMed ID: 11999352
[TBL] [Abstract][Full Text] [Related]
51. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.
Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
Cytometry B Clin Cytom; 2005 Mar; 64(1):9-17. PubMed ID: 15668954
[TBL] [Abstract][Full Text] [Related]
52. Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome.
Durrani J; Maciejewski JP
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):97-104. PubMed ID: 31808900
[TBL] [Abstract][Full Text] [Related]
53. [Relationship between the occurrences of AL, MDS and AA and abnormal BM proliferation of patient's parents].
Feng BZ; Lei JL; Lin ZX; Shao ZH; Wang Q
Yi Chuan Xue Bao; 1998 Apr; 25(2):103-11. PubMed ID: 9752008
[TBL] [Abstract][Full Text] [Related]
54. Aplastic anaemia versus hypocellular myelodysplastic syndrome.
Varma N; Varma S; Marwaha N; Garewal G
Indian J Cancer; 1995 Sep; 32(3):110-5. PubMed ID: 8772810
[TBL] [Abstract][Full Text] [Related]
55. Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes.
Berer A; Jäger E; Sagaster V; Streubel B; Wimazal F; Sperr WR; Welterman A; Schwarzinger I; Frommlet F; Haas OA; Valent P; Lechner K; Geissler K; Ohler L
Ann Hematol; 2003 May; 82(5):271-7. PubMed ID: 12739063
[TBL] [Abstract][Full Text] [Related]
56. Flow cytochemical patterns of white blood cells in human hematopoietic malignancies: III. Miscellaneous hemopoietic diseases.
Drewinko B; Bollinger P; Brailas C; Wyatt J; Simson E; Trujillo JM
Blood Cells; 1988; 13(3):475-86. PubMed ID: 3382753
[TBL] [Abstract][Full Text] [Related]
57. Detection of GPI-anchored protein-deficient cells in patients with aplastic anaemia and evidence for clonal expansion during the clinical course.
Kawaguchi K; Wada H; Mori A; Takemoto Y; Kakishita E; Kanamaru A
Br J Haematol; 1999 Apr; 105(1):80-4. PubMed ID: 10233366
[TBL] [Abstract][Full Text] [Related]
58. [Clinical features of atypical refractory anemia (RA)].
Matsuda A; Jinnai I; Kusumoto S; Shiramatsu F; Bessho M; Saito M; Hirashima K
Rinsho Ketsueki; 1991 Aug; 32(8):855-61. PubMed ID: 1942525
[TBL] [Abstract][Full Text] [Related]
59. Spontaneous remission of aplastic anemia: a retrospective analysis.
Lee JH; Lee JH; Shin YR; Lee JS; Kim WK; Chi HS; Park CJ; Lee KH
Haematologica; 2001 Sep; 86(9):928-33. PubMed ID: 11532620
[TBL] [Abstract][Full Text] [Related]
60. Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes.
Wulfert M; Küpper AC; Tapprich C; Bottomley SS; Bowen D; Germing U; Haas R; Gattermann N
Exp Hematol; 2008 May; 36(5):577-86. PubMed ID: 18439489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
